Interestingly, sulpiride

(vehicle, 25, 50 ng/side) injection in both the core and the shell of the accumbens affected step-through latency 24 h later; also, in this case the impairment was time dependent. These data provide the most complete and direct demonstration to date that early consolidation of aversive CBL0137 memory requires D2 receptor activation in both nucleus accumbens subregions, and D1 activation selectively in the nucleus accumbens core.”
“There is growing evidence that neuropeptide Y (NPY) acting through Y1 and Y2 receptors has a prominent role in modulating anxiety- and depression-like behavior in rodents. However, a role of other Y-receptors like that of Y4 receptors in this process is poorly understood. We now investigated male Y2, Y4 single and Y2/Y4 double knockout mice In behavioral paradigms for changes in motor activity, anxiety and depression-like behavior. Motor activity was increased in Y2, Y4 and Y2/Y4 knockout mice under changing and stressful conditions, but not altered in a familiar environment. Y4 and Y2 knockout mice revealed an anxiolytic phenotype in the light/dark test, marble burying test and in stress-induced PKC412 in vitro hyperthermia, and reduced depression-like behavior In the forced swim and tall suspension tests. In Y2/Y4 double knockout mice, the response in the light/dark test and in the forced swim test was further enhanced compared with Y4 and

Y2 knockout mice, respectively. High levels of Y4 binding sites were observed in brain stem nuclei including nucleus of solitary tract and area postrema. Lower levels were found in the medial amygdala and hypothalamus. Peripheral administration of pancreatic polypeptide (PP) Induced Y4 receptor-dependent c-Fos expression in brain stem, hypothalamus and amygdala. PP

released peripherally from the pancreas In response to food intake, may act not only as a satiety signal but also modulate anxiety-related locomotion. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.”
“Rats selleckchem were subjected to one or two cycles of fear conditioning and extinction, injected with a benzodiazepine, midazolam, before the first or second extinction, and tested for long-term inhibition of fear responses (freezing). In Experiment 1, inhibition of context-conditioned fear was spared when midazolam was injected before the second extinction, but impaired when injected before the first. In Experiment 2, it was spared when midazolam was injected before the second extinction, but only if vehicle had been injected before the first: Inhibition was impaired when the drug was injected before both. In Experiment 3, inhibition of a discrete conditioned stimulus (CS A) was spared when midazolam was injected before its second extinction, but impaired when injected before extinction of CS A in rats that had undergone extinction of CS B.